BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//DataCutoff//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DataCutoff · $TEVA readouts
X-WR-CALDESC:Clinical-trial primary completion dates from ClinicalTrials.go
 v\, refreshed nightly by DataCutoff. Not investment advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06052267-pcd@datacutoff.com
DTSTAMP:20261118T192902Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:TEV-56248 readout (P3) · Teva Branded Pharmaceutical Products R&D 
 LLC $TEVA
DESCRIPTION:A Study to Test if a Fixed-Dose Combination of Fluticasone Prop
 ionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations\n
 \nPrimary completion date: 2026-12-31 (estimated)\nOriginally planned: 202
 6-07-29 (+5.1 months)\nPhase 3 · Respiratory · Asthma\nEnrollment: 2769 
 · Sites: 391\n\nPrimary completion = last participant's primary-endpoint 
 data collected\; topline results usually follow weeks to months later. Spo
 nsor-reported\, often an estimate. Not investment advice.\n\nhttps://datac
 utoff.com/radar.html?nct=NCT06052267\nhttps://clinicaltrials.gov/study/NCT
 06052267
URL:https://datacutoff.com/radar.html?nct=NCT06052267
CATEGORIES:Respiratory,Phase 3
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06568237-pcd@datacutoff.com
DTSTAMP:20261118T192902Z
DTSTART;VALUE=DATE:20270915
DTEND;VALUE=DATE:20270916
SUMMARY:TOPAS-MSA readout (P2) · Teva Branded Pharmaceutical Products R&D 
 LLC $TEVA
DESCRIPTION:A Trial to Test if TEV-56286 is Effective for Treatment of Part
 icipants With Multiple System Atrophy\n\nPrimary completion date: 2027-09-
 15 (estimated)\nOriginally planned: 2027-05-18 (+3.9 months)\nPhase 2 · N
 euro · Multiple System Atrophy\nEnrollment: 349 · Sites: 61\n\nPrimary c
 ompletion = last participant's primary-endpoint data collected\; topline r
 esults usually follow weeks to months later. Sponsor-reported\, often an e
 stimate. Not investment advice.\n\nhttps://datacutoff.com/radar.html?nct=N
 CT06568237\nhttps://clinicaltrials.gov/study/NCT06568237
URL:https://datacutoff.com/radar.html?nct=NCT06568237
CATEGORIES:Neuro,Phase 2
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
